bosentan anhydrous has been researched along with Hemangioma, Capillary in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adachi, S; Hirashiki, A; Kondo, T; Matsubara, H; Miyaji, K; Murohara, T; Nakaguro, M; Ogawa, A; Yokoi, T | 1 |
Brasch, F; Bucher, B; Casaulta, C; Griese, M; Navarini, S; Pavlovic, M; Pfammatter, JP; Regamey, N | 1 |
2 other study(ies) available for bosentan anhydrous and Hemangioma, Capillary
Article | Year |
---|---|
Imatinib is partially effective for the treatment of pulmonary capillary hemangiomatosis.
Topics: Adult; Antihypertensive Agents; Antineoplastic Agents; Autopsy; Benzamides; Bosentan; Cardiac Catheterization; Dyspnea; Echocardiography; Epoprostenol; Fatal Outcome; Hemangioma, Capillary; Humans; Hypertension, Pulmonary; Imatinib Mesylate; Lung; Lung Neoplasms; Male; Piperazines; Purines; Pyrimidines; Radiography, Thoracic; Sildenafil Citrate; Sulfonamides; Treatment Failure | 2014 |
Pulmonary hypertension presenting with apnea, cyanosis, and failure to thrive in a young child.
Topics: Antihypertensive Agents; Apnea; Biopsy; Bosentan; Cyanosis; Failure to Thrive; Familial Primary Pulmonary Hypertension; Fatal Outcome; Female; Hemangioma, Capillary; Humans; Hypertension, Pulmonary; Infant; Lung; Lung Neoplasms; Radiography, Thoracic; Sulfonamides | 2011 |